Amniosenteesiin

Amniosenteesiin is a medical procedure performed during pregnancy. It involves the withdrawal of a small amount of amniotic fluid from the uterus. This fluid contains fetal cells that can be used for various diagnostic tests. The procedure is typically performed between the 15th and 20th week of gestation, though it can be done later if necessary.

The primary purpose of amniocenteesiin is to obtain fetal cells for genetic testing. These tests can detect chromosomal abnormalities such as Down syndrome, as well as other genetic disorders like cystic fibrosis and Tay-Sachs disease. Amniotic fluid can also be analyzed to assess fetal lung maturity, detect infections, and determine the presence of Rh incompatibility.

Amniosenteesiin is usually recommended for pregnant individuals who have a higher risk of certain genetic conditions, such as those with a family history of genetic disorders, advanced maternal age, or abnormal results from earlier screening tests. While generally safe, the procedure carries a small risk of complications, including miscarriage, infection, and leakage of amniotic fluid. The needle is guided by ultrasound to ensure accuracy and minimize risk to the fetus. After the procedure, patients are typically advised to rest and avoid strenuous activity for a short period. The results of the tests can take several weeks to become available.